Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial.
Lavigne D, Hijal T, Vavassis P, Guilbert MC, Sideris L, Dubé P, Gervais MK, Leblanc G, Dufresne MP, Nguyen D, Tiberi D, Mahmoud D, Yassa M. Lavigne D, et al. Radiother Oncol. 2024 Nov;200:110515. doi: 10.1016/j.radonc.2024.110515. Epub 2024 Aug 30. Radiother Oncol. 2024. PMID: 39218041 Free article. Clinical Trial.
Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study.
Mahmoud D, Yassa M, Alvarado L, Lambert C, Meterissian S, Anderson D, Tremblay F, Otaky N, Keyserlingk J, Panet-Raymond V, Kopek N, David M, Duclos M, Pembroke C, Fleiszer D, Meguerditchian AN, Loutfi A, Lavigne D, Hijal T. Mahmoud D, et al. Among authors: lavigne d. Radiother Oncol. 2024 Nov;200:110510. doi: 10.1016/j.radonc.2024.110510. Epub 2024 Aug 30. Radiother Oncol. 2024. PMID: 39218040 Free article. Clinical Trial.
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.
Fingerman DF, O'Leary DR, Hansen AR, Tran T, Harris BR, DeWeerd RA, Hayer KE, Fan J, Chen E, Tennakoon M, Meroni A, Szeto JH, Devenport J, LaVigne D, Weitzman MD, Shalem O, Bednarski J, Vindigni A, Zhao X, Green AM. Fingerman DF, et al. Among authors: lavigne d. EMBO J. 2024 Aug;43(15):3240-3255. doi: 10.1038/s44318-024-00137-x. Epub 2024 Jun 17. EMBO J. 2024. PMID: 38886582 Free PMC article.
Concurrent Olaparib and Radiation Therapy for BRCA2-Mutated Breast Cancer.
Lavigne D, Sideris L, de Guerke L, Marchand EL, Fortin S, Dubé P, Vavassis P, Auclair MH, Yassa M. Lavigne D, et al. Adv Radiat Oncol. 2024 Apr 27;9(7):101528. doi: 10.1016/j.adro.2024.101528. eCollection 2024 Jul. Adv Radiat Oncol. 2024. PMID: 38799106 Free PMC article. No abstract available.
Evaluation of a National Radiation Oncology Research and Mentorship Program.
Jin R, Wu CHD, Giuliani M, Doll C, Ringash J, Lavigne D, Ingledew PA. Jin R, et al. Among authors: lavigne d. Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):323-331. doi: 10.1016/j.ijrobp.2024.03.040. Epub 2024 Apr 4. Int J Radiat Oncol Biol Phys. 2024. PMID: 38582234
Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei.
Roster CP, LaVigne D, Milanes JE, Knight E, Anderson HD, Pizarro S, Harding EM, Morris MT, Yan VC, Pham CD, Muller F, Kwain S, Rees KC, Dominy B, Whitehead DC, Uddin MN, Millward SW, Morris JC. Roster CP, et al. Among authors: lavigne d. Pathogens. 2023 Oct 28;12(11):1290. doi: 10.3390/pathogens12111290. Pathogens. 2023. PMID: 38003754 Free PMC article.
48 results